Data and document sharing pose significant challenges, even for well-established Life Sciences companies. Conflicting regulatory guidelines, legacy data sets, countless global registries, insufficient resources dedicated to disclosure, and complex lifecycle management processes are just a few of the obstacles that make it easy to miss important sharing deadlines.
De-Identification Services provided by Instem help sponsors meet regulatory guidelines for public disclosure and internal sharing to confidently and consistently share on any scale. Available on-demand and without investment into additional software or internal resources, the transparency experts at Instem will anonymize and measure risk for data sets and clinical study reports and can provide redaction services when necessary.
